Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches
In this second study, we established syngeneic in vivo models named carcinogen-induced mouse-derived isografts (cMDIs). Carcinogen-induced tumors were obtained during short-term observation (3⁻9 months) of CBA/J mice treated with various administration routes with 3-methylcholanthrene (MCA...
Main Authors: | Janette Beshay, Peter Jantscheff, Thomas Lemarchand, Cynthia Obodozie, Christoph Schächtele, Holger Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/242 |
Similar Items
-
Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches
by: Peter Jantscheff, et al.
Published: (2019-02-01) -
HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies
by: Ziva Modic, et al.
Published: (2023-06-01) -
Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer
by: Wei-Chiao Chiu, et al.
Published: (2022-08-01) -
Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts
by: Csaba András Schvarcz, et al.
Published: (2021-04-01) -
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors
by: Barbara Costa, et al.
Published: (2021-01-01)